Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach

Human leukocyte antigens (HLAs) are pivotal in antigen processing, presenting to CD4+ T cells, and are linked to autoimmune disease susceptibility. In celiac disease, HLA-DQ2.5 and HLA-DQ8.1 bind gluten peptides on APCs, some recognized by CD4+ T cells, prompting inflammation and tissue damage. Whil...

Full description

Bibliographic Details
Main Authors: Mariyana Atanasova, Ivan Dimitrov, Antonio Fernandez, Javier Moreno, Frits Koning, Irini Doytchinova
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/1/138
_version_ 1827384640874217472
author Mariyana Atanasova
Ivan Dimitrov
Antonio Fernandez
Javier Moreno
Frits Koning
Irini Doytchinova
author_facet Mariyana Atanasova
Ivan Dimitrov
Antonio Fernandez
Javier Moreno
Frits Koning
Irini Doytchinova
author_sort Mariyana Atanasova
collection DOAJ
description Human leukocyte antigens (HLAs) are pivotal in antigen processing, presenting to CD4+ T cells, and are linked to autoimmune disease susceptibility. In celiac disease, HLA-DQ2.5 and HLA-DQ8.1 bind gluten peptides on APCs, some recognized by CD4+ T cells, prompting inflammation and tissue damage. While extensively studied experimentally, these alleles lack comprehensive in silico analysis. To explore peptide–HLA preferences, we used molecular docking on peptide libraries, deriving quantitative matrices (QMs) for evaluating amino acids at nine-residue peptide binding cores. Our findings tie specific residue preferences to peptide backbone conformations. Validating QMs on known binders and non-binders showed strong predictive power (89–94% accuracy). These QMs excel in screening protein libraries, even whole proteomes, notably reducing time and costs for celiac disease risk assessment in novel proteins. This computational approach aligns with European Food Safety Authority guidance, promising efficient screening for potential celiac disease triggers.
first_indexed 2024-03-08T15:01:57Z
format Article
id doaj.art-f46cbfc366db42c6ae22a18890e7c8cc
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-08T15:01:57Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-f46cbfc366db42c6ae22a18890e7c8cc2024-01-10T15:04:17ZengMDPI AGMolecules1420-30492023-12-0129113810.3390/molecules29010138Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based ApproachMariyana Atanasova0Ivan Dimitrov1Antonio Fernandez2Javier Moreno3Frits Koning4Irini Doytchinova5Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaEuropean Food Safety Authority, 43126 Parma, ItalyInstituto de Investigación en Ciencias de la Alimentación (CIAL), Consejo Superior de Investigaciones Cientificas-Universidad Autonoma de Madrid (CSIC-UAM), Campus of Interntional Excellence—CEI (UAM+CSIC), Nicolás Cabrera, 9, 28049 Madrid, SpainDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre, 2333 ZA Leiden, The NetherlandsFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaHuman leukocyte antigens (HLAs) are pivotal in antigen processing, presenting to CD4+ T cells, and are linked to autoimmune disease susceptibility. In celiac disease, HLA-DQ2.5 and HLA-DQ8.1 bind gluten peptides on APCs, some recognized by CD4+ T cells, prompting inflammation and tissue damage. While extensively studied experimentally, these alleles lack comprehensive in silico analysis. To explore peptide–HLA preferences, we used molecular docking on peptide libraries, deriving quantitative matrices (QMs) for evaluating amino acids at nine-residue peptide binding cores. Our findings tie specific residue preferences to peptide backbone conformations. Validating QMs on known binders and non-binders showed strong predictive power (89–94% accuracy). These QMs excel in screening protein libraries, even whole proteomes, notably reducing time and costs for celiac disease risk assessment in novel proteins. This computational approach aligns with European Food Safety Authority guidance, promising efficient screening for potential celiac disease triggers.https://www.mdpi.com/1420-3049/29/1/138celiac diseaseHLA-DQ2.5HLA-DQ8.1molecular dockingquantitative matrixpeptide binding prediction
spellingShingle Mariyana Atanasova
Ivan Dimitrov
Antonio Fernandez
Javier Moreno
Frits Koning
Irini Doytchinova
Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
Molecules
celiac disease
HLA-DQ2.5
HLA-DQ8.1
molecular docking
quantitative matrix
peptide binding prediction
title Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
title_full Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
title_fullStr Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
title_full_unstemmed Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
title_short Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
title_sort assessment of novel proteins triggering celiac disease via docking based approach
topic celiac disease
HLA-DQ2.5
HLA-DQ8.1
molecular docking
quantitative matrix
peptide binding prediction
url https://www.mdpi.com/1420-3049/29/1/138
work_keys_str_mv AT mariyanaatanasova assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach
AT ivandimitrov assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach
AT antoniofernandez assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach
AT javiermoreno assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach
AT fritskoning assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach
AT irinidoytchinova assessmentofnovelproteinstriggeringceliacdiseaseviadockingbasedapproach